Bangkok Genomics Innovation Public Company Limited (BKGI) Stock Statistics & Valuation Metrics

Bangkok Genomics Innovation Public Company Limited has a market cap or net worth of THB 1.26B. The enterprise value is THB 1.12B.

Market Cap

THB 1.26B

Enterprise Value

THB 1.12B

Bangkok Genomics Innovation Public Company Limited has 600,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

600,000,000

Owned by Insiders

―

Owned by Institutions

―

Bangkok Genomics Innovation Public Company Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 6.93%.

Return on Equity (ROE)

0.08

Return on Assets (ROA)

0.06

Return on Invested Capital (ROIC)

6.93%

Return on Capital Employed (ROCE)

0.07

Revenue Per Employee

10.26M

Profits Per Employee

1.23M

Employee Count

37

Asset Turnover

0.54

Inventory Turnover

6.36

The current PE Ratio of Bangkok Genomics Innovation Public Company Limited is 11.19. Bangkok Genomics Innovation Public Company Limited’s PEG ratio is 0.04.

PE Ratio

11.19

PS Ratio

2.12

PB Ratio

2.07

Price to FCF

-64.49

Price to Operating Cash Flow

52.42

PEG Ratio

0.04

In the last 12 months, Bangkok Genomics Innovation Public Company Limited had revenue of 379.51M and earned 45.35M in profits. Earnings per share was 0.08.

Revenue

379.51M

Gross Profit

150.04M

Operating Income

42.40M

Pretax Income

47.85M

Net Income

45.35M

EBITDA

63.95M

Earnings Per Share (EPS)

0.08

In the last 12 months, operating cash flow was -28.85M and capital expenditures -57.15M, giving a free cash flow of -85.99M billion.

Operating Cash Flow

-28.85M

Free Cash Flow

-85.99M

Free Cash Flow per Share

-0.03

Bangkok Genomics Innovation Public Company Limited pays an annual dividend of ―, resulting in a dividend yield of 2.38%

Dividend Per Share

―

Dividend Yield

2.38%

Payout Ratio

N/A

Free Cash Flow Yield

-1.55%

Earnings Yield

8.93%

Beta

1.30

52-Week Price Change

42.86%

50-Day Moving Average

2.35

200-Day Moving Average

1.85

Relative Strength Index (RSI)

31.96

Average Volume (3m)

1.16M

Bangkok Genomics Innovation Public Company Limited upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 09, 2026

Next Earnings Date

Mar 03, 2027

Ex-Dividend Date

―

Bangkok Genomics Innovation Public Company Limited as a current ratio of 4.58, with Debt / Equity ratio of 3.90%

Current Ratio

4.58

Quick Ratio

4.29

Debt to Market Cap

0.00

Net Debt to EBITDA

-3.13

Interest Coverage Ratio

29.40

In the past 12 months, Bangkok Genomics Innovation Public Company Limited has paid 2.52M in taxes.

Income Tax

2.52M

Effective Tax Rate

0.05

Bangkok Genomics Innovation Public Company Limited EV to EBITDA ratio is 7.00, with an EV/FCF ratio of -51.24.

EV to Sales

1.69

EV to EBITDA

7.00

EV to Free Cash Flow

-51.24

EV to Operating Cash Flow

41.65

Bangkok Genomics Innovation Public Company Limited has THB 232.95M in cash and marketable securities with THB 19.08M in debt, giving a net cash position of THB 213.87M billion.

Cash & Marketable Securities

THB 232.95M

Total Debt

THB 19.08M

Net Cash

THB 213.87M

Net Cash Per Share

THB 0.36

Tangible Book Value Per Share

THB 0.94

Gross margin is 39.40%, with operating margin of 19.88%, and net profit margin of 18.96%.

Gross Margin

39.40%

Operating Margin

19.88%

Pretax Margin

20.59%

Net Profit Margin

18.96%

EBITDA Margin

24.09%

EBIT Margin

19.88%

The average price target for Bangkok Genomics Innovation Public Company Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

78.27%

EPS Growth Forecast

255.30%